Wikidata

(Q82066071)

English

A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone

scientific article published on 17 October 2011

In more languages

Statements

title
A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22006202
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22006202%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 January 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q82066071&oldid=1759857113"